weight loss shot semaglutide near me SkinnyRx SkinnyRx | Compounded Injectable Semaglutide

As more New Zealanders explore medical options for managing obesity, semaglutide has become a widely discussed tool

Check your GLP-1 receptor gene variants linked to weight loss response

PlexusDx explains how these treatments interact, what clinical evidence shows, and how to optimize both for weight loss and hormone balance

Access expert care, support research, and discover new treatment options.

- Avexitide is a novel, first-in-class GLP-1 receptor antagonist with the potential to treat hyperinsulinemic hypoglycemia - FDA Breakthrough Therapy Designation granted for avexitide for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism - Acquisition builds on Amylyx endocrine and neuroscience expertise and aligns with pipeline focus of delivering important potential treatment options to communities with high unmet needs - Phase 3 program for avexitide in PBH expected to begin in Q1 2025, with data readout anticipated in 2026